Ayene, Iraimoudi S <br/><br/>
Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation.  [electronic resource] 

 -  Molecular cancer therapeutics  Apr 2005 
 - 529-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-04-0130  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Nuclear--genetics<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Apoptosis<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cricetinae<br/>DNA Damage<br/>DNA Repair<br/>DNA-Binding Proteins--genetics<br/>Dimerization<br/>Dose-Response Relationship, Radiation<br/>Etoposide--pharmacology<br/>Gamma Rays<br/>HeLa Cells<br/>Humans<br/>Ku Autoantigen<br/>Microscopy, Fluorescence<br/>Neoplasms--therapy<br/>Phenotype<br/>RNA, Messenger--metabolism<br/>RNA, Small Interfering--genetics<br/>Telomere--ultrastructure<br/>Time Factors<br/>Topoisomerase II Inhibitors<br/>Transfection<br/>VDJ Recombinases--metabolism